NEW YORK (
) -- Billionaire investor
Carl Icahn
stepped up exposure to energy stocks in the second quarter, while continuing to favor healthcare and technology stocks, according to latest portfolio disclosures with the Securities and Exchange Commission.
Energy was a theme for Icahn in the second quarter. He added
Anadarko Petroleum
(APC) - Get Report
during the second quarter, even as it tanked nearly 30% following the
BP
(BP) - Get Report
oil spill. Icahn also bought shares in UK-based oil major
Ensco
(ESV)
and
NRG Energy
(NRG) - Get Report
, while ramping up exposure to
Chesapeake Energy
(CHK) - Get Report
, which now accounts for 7.2% of the portfolio, up from 1.3% in March.
Other new positions included organic food producer
Hain Celestial
(HAIN) - Get Report
, tech stocks
Lawson Software
( LWSN),
Micros Systems
(MCRS)
and fire-arms producer
Smith & Wesson
(SWHC)
, which got a boost in June from the Supreme Court's decision to overturn a Chicago-area ban on handguns.
Motorola
( MOT),
Biogen
(BIIB) - Get Report
and
Genzyme
( GENZ) were among his top three holdings.
Icahn raised his holdings in
Lions Gate
(LGF)
, a film studio that the legendary shareholder has been battling to take over for months. But he
in
Blockbuster
(BLOKA.PK)
by nearly 80%.
Investors managing more than $100 million in assets are required to report their holdings every quarter within 45 days from the end of the quarter. The managers do not need to disclose short positions or investments in non-U.S.- listed securities and the filings are therefore only a partial disclosure of holdings.
Investors like to follow the moves of big market movers like Icahn to get cues on sectors and stocks for their own portfolios. However, information in these portfolios are often dated and the portfolio manager may have changed tack since the end of the last quarter.
RELATED STORIES:
>>Icahn Divests 80% Shares in Blockbuster
-- Reported by Shanthi Venkataraman in New York.
Follow TheStreet.com on
and become a fan on
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
